Biocon Fact Sheet, Biocon Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Biocon Fact Sheet    (BICN)


Discover Now: One Stock for Potentially Life-changing Gains


Here is the latest financial fact sheet of Biocon. For more details, see the Biocon quarterly results and Biocon share price and chart. For a sector overview, read our pharmaceuticals sector report.

BIOCON Price History

Price Rs 381.1
Mkt Cap Rs m 228,660
Vol '000 101.1
P/E X 31.5
P/CF X 15.8
EPS (TTM) Rs 12.1
% ch % 0.4
No. of shares m 600.00
% ch week % -3.3
% ch 1-mth % -8.0
% ch 12-mth % 7.9
52 week H/L Rs 487.7/320.9
(As on May 7, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BIOCON Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
BIOCON  EQUITY SHARE DATA
High Rs5544961,1621,188707 
Low Rs407397483305554 
Sales per share (Unadj.) Rs154.5167.4194.668.791.9 
Earnings per share (Unadj.) Rs24.930.534.47.616.7 
Diluted earnings per shareRs8.310.211.57.616.7 
Cash flow per share (Unadj.) Rs35.942.948.314.024.2 
Dividends per share (Unadj.) Rs5.005.001.001.001.00 
Adj. dividends per shareRs1.671.670.331.001.00 
Dividend yield (eoy) %1.01.10.10.10.2 
Book value per share (Unadj.) Rs163.1201.7241.986.3101.6 
Adj. book value per shareRs54.467.280.686.3101.6 
Shares outstanding (eoy) m200.00200.00200.00600.00600.00 
Bonus/Rights/Conversions  ---IS- 
Price / Sales ratio x3.12.74.210.96.9 
Avg P/E ratio x19.314.623.998.937.7 
P/CF ratio (eoy) x13.410.417.053.426.1 
Price / Book Value ratio x2.92.23.48.66.2 
Dividend payout %20.116.42.913.26.0 
Avg Mkt Cap Rs m96,08089,220164,440447,900378,330 
No. of employees `0007.54.49.26.16.1 
Total wages/salary Rs m5,3346,1017,4709,31111,653 
Avg. sales/employee Rs Th4,119.77,581.94,213.96,705.88,994.3 
Avg. wages/employee Rs Th711.21,381.9809.01,514.21,900.7 
Avg. net profit/employee Rs Th663.21,379.6745.2736.91,635.3 
BIOCON  INCOME DATA
Net Sales Rs m30,89833,47438,91141,23455,144 
Other income Rs m5317921,5712,0621,444 
Total revenues Rs m31,42934,26640,48243,29656,588 
Gross profit Rs m6,9587,6789,7958,29115,883 
Depreciation Rs m2,2102,4872,7723,8514,478 
Interest Rs m89293260615709 
Profit before tax Rs m5,1905,6908,3345,88712,140 
Minority Interest Rs m-3102171632139 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m1,0511,606000 
Tax Rs m9571,4221,6161,5692,123 
Profit after tax Rs m4,9746,0916,8814,53110,026 
Gross profit margin %22.522.925.220.128.8 
Effective tax rate %18.425.019.426.717.5 
Net profit margin %16.118.217.711.018.2 
BIOCON  BALANCE SHEET DATA
Current assets Rs m24,75039,70940,47741,48648,228 
Current liabilities Rs m15,97416,65716,78321,41330,376 
Net working cap to sales %28.468.960.948.732.4 
Current ratio x1.52.42.41.91.6 
Inventory Days Days5659606468 
Debtors Days Days8178839486 
Net fixed assets Rs m34,16940,14645,07350,66164,130 
Share capital Rs m1,0001,0001,0003,0003,000 
"Free" reserves Rs m31,62239,33847,37748,80857,980 
Net worth Rs m32,62240,33848,37751,80860,980 
Long term debt Rs m7,67120,72421,08218,08315,766 
Total assets Rs m63,31984,58193,94299,897121,924 
Interest coverage x59.320.433.110.618.1 
Debt to equity ratio x0.20.50.40.30.3 
Sales to assets ratio x0.50.40.40.40.5 
Return on assets %8.07.57.65.28.8 
Return on equity %15.215.114.28.716.4 
Return on capital %14.912.812.69.616.8 
Exports to sales %33.532.033.429.228.1 
Imports to sales %19.721.220.317.818.9 
Exports (fob) Rs m10,33910,71712,98812,05815,506 
Imports (cif) Rs m6,1027,1057,8997,34810,399 
Fx inflow Rs m10,99311,78912,98812,05815,506 
Fx outflow Rs m7,3718,4457,8997,34810,399 
Net fx Rs m3,6223,3445,0894,7105,107 
BIOCON  CASH FLOW
From Operations Rs m 2,107 3,706 6,400 6,621 11,546 
From Investments Rs m -5,087 -11,417 -4,985 -6,840 -7,138 
From Financial Activity Rs m 1,862 10,676 -1,775 -2,397 -2,417 
Net Cashflow Rs m -1,118 3,000 -473 -2,612 2,103 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 40.4%
Foreign collaborators 20.6%
Indian inst/Mut Fund 8.4%
FIIs 10.7%
ADR/GDR 0.0%
Free float 19.9%
Shareholders 109,995
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 20th KM, Hosur Road, Electronic City, Bangalore - 560 100
E-MAIL kiran.kumar@biocon.com WEB www.biocon.com
TELEPHONE (080) 2808 2037 FAX (080) 2852 3423
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR S. R. Batliboi & Assoc.
CHM: Kiran Mazumdar Shaw (MD) COMP SEC: Kiran Kumar YEAR OF INC: 1978 BSE CODE: 532523 FV (Rs): 5 DIV YIELD (%): 0.3

More Pharmaceuticals Company Fact Sheets:   PANACEA BIOTECH  NATCO PHARMA  FRESENIUS KABI ONCO.  SHASUN PHARMA  LUPIN  

Compare BIOCON With:   PANACEA BIOTECH  NATCO PHARMA  FRESENIUS KABI ONCO.  SHASUN PHARMA  LUPIN  

Compare BIOCON With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BIOCON

MORE ON BIOCON

COMPARE BIOCON WITH

MARKET STATS